In This Issue
This China Newsletter provides an overview of key developments during H2 2022 in the following areas:
Antitrust
- China’s Supreme Court proposed revisions to civil litigation rules under the Anti-Monopoly Law, providing more comprehensive provisions over anti-monopoly civil litigation.
.
Civil Law
- Amendment to Law on the Protection of Rights and Interests of Women took effect, enhancing the protection of women’s rights.
- China’s Supreme Court proposed new judicial interpretations regarding the Contract Part of the PRC Civil Code, proposing several material changes to the regimes regarding the formation, validity, and termination of contracts.
.
Corporate
- China updated the draft amendment to the PRC Company Law, proposing new rules regarding liability for shareholder contributions, corporate governance, director liability, and mandatory cancellation.
.
Data, Privacy & Cybersecurity
- China initiated the mechanism for personal information protection certification, and updated the Guidelines for Certification of Personal Information Cross-Border Transfers.
- MIIT issued Measures for Data Security Management in Industrial and Information Technology, clarifying the scope and classification of data in the fields of industry and information technology, as well as the obligations of data processors.
.
Foreign Investment
- NDRC and MOFCOM jointly released the Catalogue of Industries for Encouraged Foreign Investment (2022 Version), further encouraging foreign investment in advanced manufacturing, modern service, and in the central, western, and northeastern regions.
.
Medical Treatment & Health
- The NMPA released newly revised Administration Measures for Drug Recalls, designating market authorization holders (MAHs) as the key responsible entity, and revising the regulatory framework.
* This GT Newsletter is limited to non-U.S. matters and law.